Literature DB >> 9071428

Effects of cation substitutions on reverse transcriptase and on human immunodeficiency virus production.

A G Filler1, A M Lever.   

Abstract

Reverse transcription is a key aspect of the retroviral life cycle. The enzyme reverse transcriptase requires divalent cations, manganese or magnesium, for function. In some cation-dependent systems substitution of a physiological metal by a nonphysiological metal has been shown to work. We investigated the effect of different cations on HIV reverse transcriptase activity. The studies established reaction conditions for assaying different cations. A variety of transition metals were used in in vitro assays with HIV recombinant RT homodimer and some were delivered to HIV-infected cells in vitro to study effects on virus production. Most metals substituted adequately for magnesium. However, palladium showed a marked nonreversible inhibition of RT activity in vitro that correlated with reduced HIV virus production in tissue culture. A more extensive range of transition metals and divalent cations was tested for their effects on detection of HIV RT from infected cell supernatants. In these complex phenotypes were seen. In some cases the RT activity appeared to be more easily detectable. This may relate to calcium-dependent nucleases in cell supernatants being inhibited, leading to an apparent enhancement of RT activity, or may be due to direct effects on RT processivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071428     DOI: 10.1089/aid.1997.13.291

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity.

Authors:  Katherine J Fenstermacher; Jeffrey J DeStefano
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

2.  Mechanism of HIV-1 RNA dimerization in the central region of the genome and significance for viral evolution.

Authors:  Dorota Piekna-Przybylska; Gaurav Sharma; Robert A Bambara
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

3.  A recombination hot spot in HIV-1 contains guanosine runs that can form a G-quartet structure and promote strand transfer in vitro.

Authors:  Wen Shen; Lu Gao; Mini Balakrishnan; Robert A Bambara
Journal:  J Biol Chem       Date:  2009-10-12       Impact factor: 5.157

4.  Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site.

Authors:  G P Harrison; M S Mayo; E Hunter; A M Lever
Journal:  Nucleic Acids Res       Date:  1998-07-15       Impact factor: 16.971

5.  Non-nucleoside Reverse Transcriptase Inhibitors Inhibit Reverse Transcriptase through a Mutually Exclusive Interaction with Divalent Cation-dNTP Complexes.

Authors:  Jeffrey J DeStefano
Journal:  Biochemistry       Date:  2019-04-05       Impact factor: 3.321

6.  Alternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.

Authors:  Vasudevan Achuthan; Jeffrey J DeStefano
Journal:  BMC Biochem       Date:  2015-05-03       Impact factor: 4.059

7.  Manganese Ions Individually Alter the Reverse Transcription Signature of Modified Ribonucleosides.

Authors:  Marco Kristen; Johanna Plehn; Virginie Marchand; Kristina Friedland; Yuri Motorin; Mark Helm; Stephan Werner
Journal:  Genes (Basel)       Date:  2020-08-18       Impact factor: 4.096

Review 8.  Anti-HIV activity of southern African plants: Current developments, phytochemistry and future research.

Authors:  Gerhard Prinsloo; Cynthia K Marokane; Renée A Street
Journal:  J Ethnopharmacol       Date:  2017-08-12       Impact factor: 4.360

9.  U3 region in the HIV-1 genome adopts a G-quadruplex structure in its RNA and DNA sequence.

Authors:  Dorota Piekna-Przybylska; Mark A Sullivan; Gaurav Sharma; Robert A Bambara
Journal:  Biochemistry       Date:  2014-04-15       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.